Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 7, 2013, Pages 551-556

  Lu, Yung Chuan ^a   Wang, Chao Ping ^a   Hsu, Chia Chang ^a   Chiu, Cheng An ^a   Yu, Teng Hung ^a   Hung, Wei Chin ^a   Lu, Li Fen ^a   Chung, Fu Mei ^a   Tsai, I Ting ^a   Lin, Hsien Chang ^b   Lee, Yau Jiunn ^c  

^a I SHOU UNIVERSITY   (Taiwan)

^b Li Tzung biotechnology   (Taiwan)

^c Lee's Endocrinologic Clinic   (Taiwan)

Author keywords

Anti inflammatory; Secreted frizzled related protein 5; Type 2 diabetes mellitus; Wnt5a

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; SECRETED FRIZZLED RELATED PROTEIN 5; WNT5A PROTEIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIPLE LINEAR REGRESSION ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY; SECRETED FRIZZLED-RELATED PROTEIN 5; TYPE 2 DIABETES MELLITUS; WNT5A;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EYE PROTEINS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTO-ONCOGENE PROTEINS; WNT PROTEINS;

EID: 84884958533     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2426     Document Type: Article

References (22)

1. Wang CP, Chung FM, Shin SJ, Lee YJ. Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance. Rev Diabet Stud 2007; 4: 77-84.
2. Bloomgarden ZT. Adiposity and diabetes. Diabetes Care 2002; 25: 2342-2349.
3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
4. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 511-525.
5. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004; 255: 439-447.
6. Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. The evolving role of leptin and adiponectin in chronic liver diseases. Am J Gastroenterol 2006; 101: 2629-2640.
7. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18: 313-325.
8. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783.
9. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52: 1201-1210.
10. Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010; 329: 454-457.
11. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J Biol Chem 2000; 275: 9047-9054.
12. Koza RA, Nikonova L, Hogan J, et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2006; 2: e81.
13. Lv C, Jiang Y, Wang H, Chen B. Sfrp5 expression and secretion in adipocyte are upregulated during the differentiation and are negatively correlated with insulin resistance. Cell Biol Int 2012 [Epub ahead of print].
14. Kikuchi A, Yamamoto H, Sato A, Matsumoto S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol (Oxf) 2012; 204: 17-33.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35(Suppl 1): S64-S71.
16. Chiu CA, Lu LF, Yu TH, et al. Increased levels of total p-cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy. Rev Diabet Stud 2010; 7: 275-284.
17. Wang CP, Hung WC, Yu TH, et al. Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history. Exp Clin Endocrinol Diabetes 2010; 118: 346-352.
18. Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ. Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 2005; 28: 1710-1717.
19. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 295-299.
20. Bilkovski R, Schulte DM, Oberhauser F, et al. Role of WNT-5a in the determination of human mesenchymal stem cells into preadipocytes. J Biol Chem 2010; 285: 6170-6178.
21. Bilkovski R, Schulte DM, Oberhauser F, et al. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. Int J Obes 2011; 35: 1450-1454.
22. Schulte DM, Müller N, Neumann K, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One 2012; 7: e32437.